查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球分子细胞遗传学市场
市场调查报告书
商品编码
1296892

2023-2030年全球分子细胞遗传学市场

Global Molecular Cytogenetics Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 155 Pages | 商品交期: 2-3个工作天内

价格

荧光原位杂交（FISH）研究是癌症和白血病诊断和临床研究以及诊断的重要工具。FISH可用于评估染色体异常，其荧光标记的DNA探针针对特定的DNA序列。基于FISH的测试和比较基因组杂交（CGH），以及多色核型，已经在临床应用中得到利用。这些测试可以对基因组失衡进行全局扫描，并解决复杂的核型畸变问题。跨物种阵列CGH分析已被用于癌症基因的鉴定。

FISH的临床效果至关重要，主要是在血液病的诊断、预后和治疗决策方面，这有利于个性化医疗领域的发展。分子细胞遗传学能够正确区分致癌细胞和正常细胞，这反过来又导致了它在癌症诊断中的应用。此外，由于下一代测序（NGS）的出现和个性化药物研究的增加，该市场有很大的增长机会。然而，限制市场增长的某些因素包括仪器的高成本和不利于基因组工具的报销政策。

目录

第一章：报告摘要

  • 当前行业分析和增长潜力展望
  • 研究方法和工具
  • 市场细分
    • 按领域划分
    • 按地区

第二章：市场概述和洞察力

  • 报告的范围
  • 分析师的洞察力和当前的市场趋势
    • 主要发现
    • 建议
    • 总结

第三章：竞争格局

  • 主要公司分析
  • Abbott Laboratories, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • Bio-Rad Laboratories, Inc.
    • 概况
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • Illumina, Inc.
    • 进展概况
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • F. Hoffmann La-Roche AG
    • 进展概况
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • Thermo Fisher Scientific, Inc.
    • 进展概况
    • 财务分析
    • SWOT分析
  • 关键战略分析

第四章：市场细分

  • 按产品分類的全球分子细胞遗传学市场
    • 耗材
    • 软件和服务
    • 仪器
  • 按应用分類的全球分子细胞遗传学市场
    • 癌症
    • 遗传性疾病
    • 个体化医疗
  • 按技术分类的全球分子细胞遗传学市场
    • 荧光原位杂交(FISH)
    • 比较基因组杂交(CGH)
    • 其他技术

第五章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第六章：公司简介

  • Abbott Laboratories, Inc.
  • ADS Biotec Inc.
  • Agilent Technologies, Inc.
  • Applied Spectral Imaging
  • BioDot Inc.
  • Biological Industries Israel Beit Haemek Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Euroclone S.p.A.
  • F. Hoffmann La-Roche AG
  • FUJIFILM Irvine Scientific
  • Illumina, Inc.
  • Laboratory Imaging s.r.o.
  • Leica Biosystems
  • MetaSystems Hard & Software GmbH
  • Nikon Corp.
  • Oxford Gene Technology Ltd.
  • PAN-Biotech GmbH
  • Perkinelmer, Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: OMR2027343

Global molecular cytogenetics market is estimated to grow at a CAGR of 8.5% during the forecast period. The major factors contributing to the growth of the market include a significant prevalence of Cancer and increasing demand for genetic testing tools. As per the World Health Organization (WHO), the global Cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million mortality in 2018. 43.8 million persons were living with Cancer in 2018 and were diagnosed within the last 5 years. This rising prevalence of Cancer is attributed to the demand for molecular cytogenetic tools.

Fluorescence in-situ hybridization (FISH) study is a crucial tool for both diagnostics and clinical research, as well as diagnostics, in Cancer and Leukemia. FISH can be utilized to assess chromosomal abnormalities with fluorescent-labeled DNA probes that target specific DNA sequences. FISH-based tests and comparative genomic hybridization (CGH), and multicolor karyotyping, have been utilized in clinical applications. These tests allow the whole global scanning of genomic imbalances and the resolution of complex karyotypic aberrations. Cross-species array CGH analysis has been used in the identification of Cancer genes.

The clinical effect of FISH is crucial, primarily in the diagnosis, prognosis, and treatment decisions for hematological conditions, which facilitate the area of personalized medicine. Molecular cytogenetics enables to properly differentiate of Cancer-causing and normal cells, which in turn, is leading to its adoption in Cancer diagnostics. Further, the market has significant growth opportunities owing to the advent of next-generation sequencing (NGS) and increasing research on personalized medicines. However, certain factors restricting market growth include the high cost of instruments and unfavorable reimbursement policies for genomic tools.

Segmental Outlook

The global molecular cytogenetics market is segmented based on its product, application, and technique. Based on product, the market is segmented into consumables, software & services, and instruments. Based on application, the market is categorized into cancer, genetic disorders, and personalized medicine. Further, based on technique, the market is segmented into fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and others. Among the product segments, the consumables segment is expected to hold a prominent market share due to the recurring demand for consumables in diagnostic procedures.

Fluorescence in situ hybridization (FISH) is one of the major techniques in molecular cytogenetics testing.

Molecular cytogenetic techniques mainly rely on FISH, which is based on the principle of complementary hybridization of labeled DNA or RNA probes with normal or abnormal nucleic acid sequences on metaphase chromosomes, interphase cells, or tissue sections. FISH takes us to a colorful chromosome world, which involves a fluorescently labeled DNA probe hybridized to a specific genomic segment of interest. FISH can detect small chromosomal rearrangements that cannot be detected by conventional cytogenetic techniques. The use of the FISH technique enhanced the interpretation of the numerical and complex chromosomal rearrangements, bridging the gap between conventional cytogenetics and molecular biology. Therefore, it is being significantly adopted technique in genome research and cancer diagnostics. In genome research, FISH enables researchers to map and visualize the genetic material in an individual's cells, including portions of genes or specific genes. This technique may be applied to understand a range of chromosomal abnormalities and other genetic mutations.

Regional Outlooks

The global molecular cytogenetics market is further segmented based on geography, including North America, Europe, Asia-Pacific, and the Rest of the World. The market can be analyzed for a particular region or country level as per the requirement. The Asia-Pacific region is projected to experience considerable growth in the molecular cytogenetics market due to rising healthcare expenditure and increasing awareness about personalized medicine in the region.

Global Molecular Cytogenetics Market Growth, by Region 2023-2030

Source: OMR Analysis

The North American Region is anticipated to Hold a Significant Share in the Global Molecular Cytogenetics Market

Among these, the North American region is anticipated to hold a significant market share owing to the significant prevalence of Cancer, increasing funding for genome research, and significant share in life science research in the region. In addition, the presence of major players, including Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., and Illumina, Inc. are offering a potential opportunity for market growth in the region. These companies are focusing on introducing advanced molecular cytogenetics tools that will likely increase their market share.

Market Players Outlook

The major players in the global molecular cytogenetics market include Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Bio-Rad Laboratories Inc., and F. Hoffman La-Roche AG. Product launches and mergers and acquisitions are considered some key strategies adopted by the market players to increase market share and gain a competitive advantage. For instance, in January 2020, Oxford Gene Technology (OGT) introduced an NGS panel for constitutional cytogenetics research. The CytoSure Constitutional NGS Panel enables reliable and accurate detection of copy number variations (CNVs), insertion/deletions (indels), single nucleotide variations (SNVs), and loss of heterozygosity (LOH), such as in mosaic samples. It combines the advantages of NGS and microarrays in one cost-effective assay. This new launch will likely support those laboratories that are focusing on transitioning from arrays to NGS.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bio-Rad Laboratories, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Illumina, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. F. Hoffmann La-Roche AG
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Thermo Fisher Scientific, Inc.
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
  • 3.7. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Molecular Cytogenetics Market by Product
    • 4.1.1. Consumables
    • 4.1.2. Software & Services
    • 4.1.3. Instruments
  • 4.2. Global Molecular Cytogenetics Market by Application
    • 4.2.1. Cancer
    • 4.2.2. Genetic Disorders
    • 4.2.3. Personalized Medicine
  • 4.3. Global Molecular Cytogenetics Market by Technique
    • 4.3.1. Fluorescence in Situ Hybridization (FISH)
    • 4.3.2. Comparative Genomic Hybridization (CGH)
    • 4.3.3. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories, Inc.
  • 6.2. ADS Biotec Inc.
  • 6.3. Agilent Technologies, Inc.
  • 6.4. Applied Spectral Imaging
  • 6.5. BioDot Inc.
  • 6.6. Biological Industries Israel Beit Haemek Ltd.
  • 6.7. Bio-Rad Laboratories, Inc.
  • 6.8. Danaher Corp.
  • 6.9. Euroclone S.p.A.
  • 6.10. F. Hoffmann La-Roche AG
  • 6.11. FUJIFILM Irvine Scientific
  • 6.12. Illumina, Inc.
  • 6.13. Laboratory Imaging s.r.o.
  • 6.14. Leica Biosystems
  • 6.15. MetaSystems Hard & Software GmbH
  • 6.16. Nikon Corp.
  • 6.17. Oxford Gene Technology Ltd.
  • 6.18. PAN-Biotech GmbH
  • 6.19. Perkinelmer, Inc.
  • 6.20. Tecan Group Ltd.
  • 6.21. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL MOLECULAR CYTOGENETICS CONSUMABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL MOLECULAR CYTOGENETICS SOFTWARE AND SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MOLECULAR CYTOGENETICS INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL MOLECULAR CYTOGENETICS FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL MOLECULAR CYTOGENETICS FOR GENETIC DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MOLECULAR CYTOGENETICS FOR PERSONALIZED MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)
  • 10. GLOBAL FISH FOR MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CGH FOR MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL OTHER TECHNIQUES FOR MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)
  • 18. EUROPEAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 20. EUROPEAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MOLECULAR CYTOGENETICS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL MOLECULAR CYTOGENETICS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 3. GLOBAL MOLECULAR CYTOGENETICS MARKET SHARE BY TECHNIQUE, 2022 VS 2030 (%)
  • 4. GLOBAL MOLECULAR CYTOGENETICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL MOLECULAR CYTOGENETICS CONSUMABLES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL MOLECULAR CYTOGENETICS SOFTWARE AND SERVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL MOLECULAR CYTOGENETICS INSTRUMENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MOLECULAR CYTOGENETICS FOR CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MOLECULAR CYTOGENETICS FOR GENETIC DISORDERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MOLECULAR CYTOGENETICS FOR PERSONALIZED MEDICINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL FISH FOR MOLECULAR CYTOGENETICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL CGH FOR MOLECULAR CYTOGENETICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL OTHER TECHNIQUES FOR MOLECULAR CYTOGENETICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ROE MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)